Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/27/24 → 8/26/28 |
Funding
- Merck Sharp and Cohme Corporation: $12,000.00
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V118 Formulation C in Healthy Adults
- Rupp, Richard (PI)
Project: Research project